ARCHIVES

Drug Shortages: Institutions Report Halting Enrollment in Clinical Trials

This article is from The Cancer Letter archive.

Vol. 39 No. 12 | March 22, 2013

Download PDF Visit The Full Archive

Related Articles

House and Senate Appropriators Pledge to Increase Biomedical Research Funding.

March 5, 1999

Bevacizumab And Irinotecan May Increase Survival Of GBM

October 26, 2007

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982

DCPC Board Backs Diet Fit Trial

October 20, 1989

NCI Advisory Group, Other Cancer Meetings

January 30, 1976

Facilities Survey To Include All Institutions With $200,000 Or More in NCI Support

October 5, 1984